ACOR

Acorda Therapeutics, Inc.
ACOR

Overview Fund Activity
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

164 hedge funds and large institutions have $451M invested in Acorda Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 81 increasing their positions, 41 reducing their positions, and 36 closing their positions.

Holders
164
Holders Change
-22
Holders Change %
-11.83%
% of All Funds
3.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
81
Reduced
41
Closed
36
Calls
$1.82M
Puts
$1.21M
Net Calls
+$613K
Net Calls Change
+$3.26M

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$15.4M
2
PA
2
Perceptive Advisors
New York
$8.65M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$35M
4
State Street
4
State Street
Massachusetts
$29.6M
5
OAM
5
Oxford Asset Management
United Kingdom
$2.48M

Top Sellers

1
SCM
1
Scopia Capital Management
New York
$25.5M
2
ClearBridge Investments
2
ClearBridge Investments
New York
$4K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$47.5M
4
Schroder Investment Management Group
4
Schroder Investment Management Group
United Kingdom
$0
5
OM
5
Opaleye Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wolverine Trading
201
Wolverine Trading
Illinois
– – – –
CFGS
202
Concourse Financial Group Securities
Alabama
– – – –
CL
203
CSS LLC
Illinois
– – – –
QCG
204
Quadrant Capital Group
Ohio
$0 96 +96 New
5 6 7 8
9